What You Should Know:
- clock.bio, a healthspan biotechnology company based at the Milner Therapeutics Institute in Cambridge, has secured $5.3M in seed funding to advance its groundbreaking research on human rejuvenation.
- The seed funding round was led by LocalGlobe, with participation from BlueYard Capital, Onsight Ventures, and Dr. Jonathan Milner, the Founder of Abcam.
Decoding the Secrets of Cellular Rejuvenation
clock.bio has developed a proprietary aging model
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
Advancing Drug Discovery with Quantum Computing and Supercomputer Tech
McKinsey & Company estimates it takes up to 12 years to introduce a new drug to the market – a lengthy timeline comprised of many factors including technology limitations, regulatory requirements, and patient recruitment and retention. Scientific innovation and clinical trials are increasingly complex, generating more data than ever. Researchers are facing difficulties managing the volume and variety of data, turning to artificial intelligence, machine learning and advanced data architecture
Read More
Pharmacogenomic Testing in Mental Health: The Need for a Broader Approach
What if we advised people to wear seatbelts only on certain days or when driving on specific highways? Clearly, this would result in real and avoidable harm. Unfortunately, something similar has happened to millions of patients who underwent pharmacogenomics (PGx) testing to aid in selecting drugs and doses for treating depression or anxiety, tailored to their unique genetics, without considering the broader implications. In mental health treatment, patients often endure multiple therapies
Read More
Bioinformatics: Why Life Sciences Must Adopt Open Science
Today's biomedical research can be complex and time-consuming, as researchers grapple with the challenging task of managing and analyzing ever-growing volumes of complex scientific data. Leveraging advanced bioinformatics tools and techniques is crucial for transforming this data into meaningful insights. Standardization and collaboration within the bioinformatics space is the solution enabling researchers to meet the demands of today. Sharing such analyses and findings across the
Read More
Flatiron Health and Lifebit Partner to Enhance Cancer Care in Japan through Real-World Data
What You Should Know:
- Flatiron Health, and Lifebit Biotech Ltd (UK, London; hereafter “Lifebit”), are expanding their collaboration into Japan to transform cancer care, facilitating ground breaking research by allowing for safe and secure access to real-world data (RWD).
- Building on the success of their multi-year strategic partnership, Lifebit’s pioneering federated Trusted Research Environment (TRE) technology will enable safe and secure access to Flatiron Health’s high-quality
Read More
5 Ways Tech is Enhancing Patient Engagement in Clinical Trials
Patient engagement is critical on several levels. It helps inform updates to trial design and processes, it ensures critical data is collected to determine the safety and efficacy of an investigational product, and it supports patient retention for the duration of the trial. That’s why biopharma sponsors and research sites are leaning into technology to facilitate this engagement. It’s important for physicians and other healthcare professionals to be aware of this technology and how it can
Read More
Biden vs. Trump: What the US Election Means for Drug Pricing
The global landscape for medical technology, biotechnology, and life sciences is on the cusp of seismic change.
The confluence of geopolitical tensions, economic uncertainty, and evolving social values has created a complex web of challenges and opportunities for these sectors around the world.
The broad life science industry too is in the midst of a period of significant transition. While the shadow of the pandemic recedes, its effects linger in the form of a market correction
Read More
Sheba Medical Center & Mana.bio Partner to Advance AI-Driven RNA Delivery for Cancer & Autoimmune Therapies
What You Should Know:
- Sheba Medical Center, a leading Israeli hospital renowned for its medical innovation, and its innovation arm, ARC Innovation, have announced a collaborative research agreement with Mana.bio.
- The partnership aims to leverage Mana.bio's AI-powered programmable RNA delivery platform to overcome technological hurdles in RNA therapeutics, paving the way for enhanced treatments for cancer and autoimmune diseases.
Bridging Technological Gaps in RNA
Read More
Frontier Bio’s Lab-Grown Lungs Offers Hope for Drug Development
What You Should Know:
- Frontier Bio Corporation has successfully created complex microscale lung tissue by combining 3D bioprinting with the self-assembling capabilities of stem cells, mirroring the natural organ development process.
- Frontier Bio's breakthrough in lab-grown lung tissue signifies a potential turning point in the fight against respiratory diseases and the quest for viable organ transplantation options.
Addressing the Limitations of Animal Testing
Animal
Read More
Medidata Launches Patient Payments: Streamlining Clinical Trial Reimbursements
What You Should Know:
- Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced the launch of Medidata Patient Payments, a new solution that streamlines trial-related stipends and reimbursements for patients participating in clinical research.
- This offering automates the payment lifecycle and addresses the longstanding challenge of compensating participants for their time, effort, and study-related expenses,
Read More
